Barrow, Hanley, Mewhinney & Strauss’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-68
Closed -$614 366
2025
Q1
$614 Buy
68
+18
+36% +$190 ﹤0.01% 297
2024
Q4
$653 Hold
50
﹤0.01% 310
2024
Q3
$784 Buy
+50
New +$757 ﹤0.01% 312
2019
Q4
Sell
-242,121
Closed -$1.41M 333
2019
Q3
$1.41M Sell
242,121
-29,133
-11% -$131K ﹤0.01% 231
2019
Q2
$868K Sell
271,254
-13,036
-5% -$44.5K ﹤0.01% 263
2019
Q1
$1.17M Sell
284,290
-135,564
-32% -$857K ﹤0.01% 261
2018
Q4
$2.66M Buy
419,854
+240,052
+134% +$2.49M 0.01% 210
2018
Q3
$2.97M Sell
179,802
-19,938
-10% -$339K ﹤0.01% 246
2018
Q2
$3.34M Sell
199,740
-366
-0.2% -$5.92K 0.01% 248
2018
Q1
$3.11M Sell
200,106
-608
-0.3% -$10.8K ﹤0.01% 243
2017
Q4
$3.79M Sell
200,714
-17,582
-8% -$390K 0.01% 240
2017
Q3
$6.37M Sell
218,296
-1,010
-0.5% -$29.8K 0.01% 186
2017
Q2
$7.06M Buy
219,306
+8,464
+4% +$278K 0.01% 174
2017
Q1
$7.29M Buy
210,842
+7,078
+3% +$253K 0.01% 168
2016
Q4
$7.19M Buy
203,764
+48,355
+31% +$1.63M 0.01% 170
2016
Q3
$5.4M Sell
155,409
-2,864
-2% -$100K 0.01% 183
2016
Q2
$5.92M Sell
158,273
-584
-0.4% -$21.9K 0.01% 173
2016
Q1
$6.42M Buy
158,857
+6,283
+4% +$234K 0.01% 151
2015
Q4
$5.49M Buy
152,574
+2,862
+2% +$104K 0.01% 156
2015
Q3
$4.78M Hold
149,712
0.01% 160
2015
Q2
$5.09M Buy
149,712
+34,325
+30% +$1.16M 0.01% 160
2015
Q1
$3.9M Buy
+115,387
New +$4.02M 0.01% 175

Other funds holding ACH

Barrow, Hanley, Mewhinney & Strauss's ACH Position: Q2 2025 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Accendra Health (ACH) in Q2 2025, closing a stake of 68 shares — an estimated $614 sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in ACH in Q1 2015 and held it in 22 quarters. The position peaked at $7.29M in Q1 2017. 234 funds tracked by Wall St. Rank hold ACH as of Q2 2025.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Accendra Health position as of Q2 2025 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 68 Accendra Health shares in Q2 2025, an estimated $614.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Accendra Health in Q1 2015 and held it in 22 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Accendra Health position peaked at $7.29M in Q1 2017.
  • 234 funds tracked by Wall St. Rank held Accendra Health as of Q2 2025.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2025, filed 12 Aug 2025.